D.E. Shaw & Co’s GE HealthCare GEHC Stock Holding History

D.E. Shaw & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.5M	Sell	470,374 -837,294	-64%	-$66M	0.02%	858
2025 Q4	$107M	Sell	1,307,668 -764,283	-37%	-$59.5M	0.06%	379
2025 Q3	$156M	Buy	2,071,951 +220,279	+12%	+$16.4M	0.09%	257
2025 Q2	$137M	Buy	1,851,672 +1,839,430	+15,026%	+$128M	0.1%	252
2025 Q1	$988K	Sell	12,242 -13,568	-53%	-$1.17M	﹤0.01%	3087
2024 Q4	$2.02M	Buy	25,810 +7,980	+45%	+$678K	﹤0.01%	2728
2024 Q3	$1.67M	Sell	17,830 -9,486	-35%	-$796K	﹤0.01%	2849
2024 Q2	$2.13M	Sell	27,316 -33,706	-55%	-$2.75M	﹤0.01%	2608
2024 Q1	$5.55M	Sell	61,022 -11,125	-15%	-$926K	﹤0.01%	1817
2023 Q4	$5.58M	Buy	72,147 +22,298	+45%	+$1.56M	﹤0.01%	1818
2023 Q3	$3.39M	Sell	49,849 -38,552	-44%	-$2.8M	﹤0.01%	2159
2023 Q2	$7.18M	Sell	88,401 -78,945	-47%	-$6.3M	0.01%	1612
2023 Q1	$13.7M	Buy	+167,346	New	+$11.9M	0.01%	1138

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

D.E. Shaw & Co's GEHC Position: Q1 2026 in Review

D.E. Shaw & Co reduced its GE HealthCare (GEHC) stake by 64% in Q1 2026, selling an estimated $66M and leaving 470,374 shares worth $33.5M. The position accounts for 0.02% of the portfolio, ranked #858.

D.E. Shaw & Co first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $156M in Q3 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

D.E. Shaw & Co held 470,374 shares of GE HealthCare worth $33.5M as of Q1 2026.
D.E. Shaw & Co sold 837,294 GE HealthCare shares in Q1 2026, an estimated $66M.
GE HealthCare made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #858 holding.
D.E. Shaw & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
D.E. Shaw & Co's GE HealthCare position peaked at $156M in Q3 2025.
1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.